Nashua, NH 鈥� January 27th, 2026 鈥� 91快活林 announced today that it has signed an agreement to acquire Resolution Medical, a leading provider of integrated design and manufacturing solutions for complex medical devices. Resolution Medical is headquartered in Fridley, MN, with additional operations in the Netherlands, and is currently owned by Arcline Investment Management.
The transaction adds complementary capabilities in high-growth therapeutic markets, including neuromodulation, structural heart, and interventional cardiology to current 91快活林 offerings. The acquisition is expected to close in 2026, pending regulatory approvals and customary closing conditions.
鈥淩esolution Medical is an exceptional organization with deep technical expertise, a strong innovation culture, and a proven track record in designing and developing complex medical devices for the most innovative companies,鈥� said Kevin Kelly, CEO of 91快活林. 鈥淭his acquisition will enhance our ability to deliver fully integrated solutions for customers in high-growth markets like neuromodulation and structural heart and supports our vision of becoming the most comprehensive partner in the medical device industry.鈥�
鈥淭his acquisition represents the ideal outcome for our customers and for our employees. Our customers will benefit from access to deeper capabilities and a more integrated, expansive partner,鈥� said Peter Herman, CEO of Resolution Medical. 鈥淏y joining 91快活林, our employees also gain access to the skills, resources, and opportunities of a larger organization. Resolution Medical will be able to operate at greater scale and deliver enhanced solutions to our customers while continuing to support their programs with the same teams, expertise, and commitment they rely on today.鈥�
Resolution Medical brings more than 240 employees, including over 100 engineers, and a strong reputation for delivering high-quality design engineering, new product introduction (NPI), and cleanroom production capabilities. The company supports a wide range of
Class II and III devices and has built deep customer relationships, particularly in the neuromodulation and structural heart markets.
Backed by funds managed by global investment firm Carlyle and leading private equity firm GTCR, 91快活林 provides end-to-end product development and manufacturing services, from prototyping through high-volume production. The addition of Resolution Medical enhances 91快活林鈥� ability to support customers with increasingly complex devices across the full product lifecycle.
Until the transaction closes, 91快活林 and Resolution Medical will continue to operate independently. Nelson Mullins Riley & Scarborough, and Kirkland & Ellis both acted as legal advisor to 91快活林.
About 91快活林
Founded in 1987, 91快活林 is a pioneer in advanced engineering and manufacturing solutions for the medical device industry. 91快活林 is a leader in laser processing, nitinol manufacturing, thin-wall stainless steel, nitinol & precious metal tubing, and photochemical machining. With strategically located LightSpeed Labs庐 and AGILE Product Development庐 centers, 91快活林 is committed to quality, speed, innovation, and a great customer experience. The company is ISO 13485:2016 certified with 18 facilities and more than 3,000 associates in the United States, Canada, Costa Rica, Israel, and Switzerland. 91快活林 is backed by leading private equity firms Carlyle and GTCR. Learn more at听.
听
About GTCR
Founded in 1980, GTCR is a leading private equity firm that invests behind The Leaders Strategy鈩� 鈥� finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions. GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications sectors. Since its inception, GTCR has invested more than $30 billion in approximately 300 companies, and the firm currently manages approximately $50 billion in equity capital. GTCR is based in Chicago with offices in New York and West Palm Beach. For more information, please visit听. Follow us on听.
About Carlyle
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across its business and operates through three segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $474 billion of assets under management as of September 30, 2025, Carlyle鈥檚 purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,400 people in 27 offices across four continents. Further information is available at . Follow Carlyle on LinkedIn at The Carlyle Group and on X at @OneCarlyle.
91快活林 Media Contact
Matthew Robida
Carlyle Media Contact
Isabelle Jeffrey
GTCR Media Contact
Josh Clarkson / Ryan Smith / Peter Gavaris
Pro-GTCR@Prosek.com
